Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Neovastat enters clinic in the U.S.

Jan. 17, 1997

SnET2 trials now span three continents

Jan. 17, 1997

Antisense mechanism of Isis/Ciba compound demonstrated

Jan. 17, 1997

Merck & Co. claims FPTase inhibitors for cancer

Jan. 17, 1997

Anticancer/antimetastatic agents from Sankyo

Jan. 17, 1997

Fluasterone enters phase I as breast cancer prevention agent

Jan. 16, 1997

First launch for AccuSite

Jan. 16, 1997

Novel antitumor agents from Kyowa Hakko

Jan. 16, 1997

Protein tyrosine kinase inhibitors from Kyowa Hakko

Jan. 16, 1997

Gene Logic/Baylor prostate cancer collaboration

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...